{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:45:03Z","timestamp":1767789903464,"version":"3.49.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Resistance to epidermal growth factor receptor monoclonal antibodies (anti-EGFR), such as cetuximab, remains a major therapeutic challenge. Growing evidence suggests that local tumor immune cells and systemic inflammation influence therapeutic outcomes. Our study aimed to investigate the balance between nitric oxide synthase-2 (NOS2) and arginase-1 (ARG1) expression and its association with immune contexture and clinical outcome in cetuximab-treated colorectal cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>100 patients with colorectal cancer (CRC) were included in this study. NOS2 and ARG1 expression and their metabolites were assessed using RT-qPCR, immunofluorescence, and biochemical assays. Tumor-infiltrating CD68+ pan-macrophages, CD163+ M2 like- macrophage, and CD8+ T cells were assessed using immunohistochemistry and immunofluorescence. Baseline complete blood counts were used to calculate systemic immune ratios, including the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Monocyte-to-Lymphocyte Ratio (MLR), Systemic Immune-Inflammation Index (SII), and Systemic Inflammation Response Index (SIRI). Associations between NOS2\/ARG1 profiles, systemic immune cell ratios, and treatment response were analyzed using Student\u2019s t-test. Progression-free survival (PFS) and overall survival (OS) were estimated using Kaplan\u2013Meier analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NOS2 and ARG1 levels were elevated in CRC, particularly in the late stages. Low NOS2\/high ARG1 expression correlated with increased CD68+ and CD163+ cell infiltration, whereas high NOS2\/lowARG expression was associated with increased CD8+ cell density. Systemic inflammatory indices were higher in patients with CRC than in controls. In mCRC patients receiving cetuximab plus chemotherapy, responders had lower NLR, SII, SIRI, and ARG levels and higher NO levels than non-responders. High baseline SII, SIRI, and ARG levels predicted poorer PFS and OS, whereas elevated NO levels predicted better outcomes. Interestingly, a combined score integrating NO, ARG, SII, and SIRI indicated a higher prognostic value than individual markers in mCRC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study highlights the pivotal role of the NOS2\/ARG1 axis in local immune infiltration, systemic inflammation, and clinical outcomes in mCRC patients receiving cetuximab. For the first time, we propose a novel combined score integrating NO, arginase, SII, and SIRI as simple, accessible, and non-invasive prognostic and predictive markers. Our findings may open new avenues for patient stratification and treatment optimization in precision oncology research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1700487","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:35:51Z","timestamp":1767771351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["NOS2\/ARG1 axis and immune cell ratios as promising prognostic and predictive biomarkers for Cetuximab combined with chemotherapy in wt-KRAS human colorectal cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Djehane Houria","family":"Mataam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assia","family":"Galleze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra","family":"Benkhelifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryad","family":"Trari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Khelaifia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Belhadef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Bouhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Ait Younes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anissa","family":"Benali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Mahfouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houda","family":"Belguendouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadira","family":"Delhem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chafia","family":"Touil-Boukoffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayet","family":"Rafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistic","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i10.1569","article-title":"Systemic treatment for metastatic colorectal cancer","volume":"29","author":"Leowattana","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B3","article-title":"SEER cancer statistics review: colorectal cancer\u20145-year relative survival by stage","year":"2024","journal-title":"Surveillance, Epidemiology, and End Results (SEER) Program, National Institutes of Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.4c00008","article-title":"Advances in precision medicine approaches for colorectal cancer: from molecular profiling to targeted therapies","volume":"7","author":"Kiran","year":"2024","journal-title":"ACS Pharmacol Trans Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1048166","article-title":"Current concepts of anti-EGFR targeting in metastatic colorectal cancer","volume":"12","author":"Doleschal","year":"2022","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7150\/jca.111828","article-title":"Predictive and prognostic biomarkers of recurrence in locoregional colorectal cancer","volume":"16","author":"Cendra","year":"2025","journal-title":"J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00495-z","article-title":"Precision oncology in metastatic colorectal cancer \u2014 from biology to medicine","volume":"18","author":"Di Nicolantonio","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1532971","article-title":"Precision medicine in colorectal cancer: genomics profiling and targeted treatment","volume":"16","author":"Muradi Muhar","year":"2025","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1450117","article-title":"Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity","volume":"19","author":"Baretti","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1186\/s12885-023-11600-z","article-title":"Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis","volume":"23","author":"Lu","year":"2023","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01423","article-title":"Resistance mechanisms to anti\u2013epidermal growth factor receptor therapy in RAS\/RAF wild-type colorectal cancer vary by regimen and line of therapy","volume":"41","author":"Parseghian","year":"2023","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172804","article-title":"Anti-EGFR therapy in metastatic colorectal cancer: identifying, tracking, and overcoming resistance","volume":"17","author":"Leite","year":"2025","journal-title":"Cancers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1120009x.2023.2300224","article-title":"The tumor microenvironment: shaping cancer progression and treatment response","volume":"37","author":"Desai","year":"2025","journal-title":"J Chemotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B16","first-page":"01016","article-title":"Single-cell RNA sequencing reveals immunosuppressive mechanisms of MDSCs in lung cancer","volume-title":"BIO Web of Conferences","author":"Liu","year":"2025"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_41_24","article-title":"Prognostic value of tumor-infiltrating lymphocyte subtypes and microorganisms in triple-negative breast cancer","volume":"20","author":"Shi","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"35138","DOI":"10.1038\/s41598-025-19003-9","article-title":"CD68- and CD163-positive tumor-associated macrophages in renal clear cell carcinoma","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/0284186x.2023.2228991","article-title":"Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study","volume":"62","author":"Zhang","year":"2023","journal-title":"Acta Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-025-06291-y","article-title":"New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy","volume":"23","author":"Lin","year":"2025","journal-title":"J Trans Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100741","article-title":"Tumor-associated macrophages: polarization, immunoregulation, and immunotherapy","volume":"14","author":"Saeed","year":"2025","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102655","article-title":"Regulation of T cells in cancer by nitric oxide","volume":"10","author":"Navasardyan","year":"2021","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80721","article-title":"Arginase 1 is a key driver of immune suppression in pancreatic cancer","volume":"12","author":"Menjivar","year":"2023","journal-title":"eLife"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-025-01038-9","article-title":"Arginine metabolism in myeloid cells in health and disease","volume":"47","author":"Karadima","year":"2025","journal-title":"Semin Immunopathology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.843074","article-title":"Blood-cell-based inflammatory markers as a useful tool for early diagnosis in colorectal cancer","volume":"9","author":"Hernandez-Ainsa","year":"2022","journal-title":"Front Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i24.3059","article-title":"Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer","volume":"30","author":"Ba","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7353252","article-title":"All-trans retinoic acid modulates TLR4\/NF-\u03baB signaling pathway targeting TNF-\u03b1and nitric oxide synthase 2 expression in colonic mucosa during ulcerative colitis and colitis associated cancer","author":"Rafa","year":"2017","journal-title":"Mediators Inflammation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10787-019-00566-9","article-title":"Aberrant up-regulation of iNOS\/NO system is correlated with an increased abundance of Foxp3+ cells and reduced effector\/memory cell markers expression during colorectal cancer: immunomodulatory effects of cetuximab combined with chemotherapy","volume":"27","author":"Benkhelifa","year":"2019","journal-title":"Inflammopharmacology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9084(99)80027-3","article-title":"Production of nitric oxide (NO) in human hydatidosis: Relationship between nitrite production and interferon-\u03b3 levels","volume":"80","author":"Touil-Boukoffa","year":"1998","journal-title":"Biochimie"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.1094","article-title":"Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages","volume":"206","author":"Corraliza","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092594","article-title":"L-arginine\/nitric oxide pathway is altered in colorectal cancer and can be modulated by novel derivatives from Oxicam class of non-steroidal anti-inflammatory drugs","volume":"12","author":"Krzystek-Korpacka","year":"2020","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.658861","article-title":"Arginine metabolism and its potential in treatment of colorectal cancer","volume":"9","author":"Du","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biology11030385","article-title":"Correlation between lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and tumor-infiltrating lymphocytes (TILs) in left-sided colorectal cancer patients","volume":"11","author":"Gawi\u0144ski","year":"2022","journal-title":"Biology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113276","article-title":"iNOS expression by tumor-infiltrating lymphocytes, PD-L1 and prognosis in non-small-cell lung cancer","volume":"12","author":"Giatromanolaki","year":"2020","journal-title":"Cancers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217680","article-title":"The arginine metabolism and its deprivation in cancer therapy","volume":"620","author":"Feng","year":"2025","journal-title":"Cancer Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"18741","DOI":"10.1038\/s41598-025-03446-1","article-title":"Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity","volume":"15","author":"Grzybowski","year":"2025","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"152383","DOI":"10.1016\/j.prp.2019.03.012","article-title":"Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer","volume":"215","author":"Ma","year":"2019","journal-title":"Pathol - Res Pract"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112840","article-title":"Arginase: An emerging and promising therapeutic target for cancer treatment","volume":"149","author":"Niu","year":"2022","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13211","article-title":"A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225449","article-title":"Arginase-1 in plasma-derived exosomes as marker of metastasis in patients with head and neck squamous cell carcinoma","volume":"15","author":"Hofmann","year":"2023","journal-title":"Cancers"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-022-00301-z","article-title":"Arginase-1 inhibition reduces migration ability and metastatic colonization of colon cancer cells","volume":"11","author":"Wang","year":"2023","journal-title":"Cancer Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1133946","article-title":"Development of a prognostic model based on ferroptosis-related genes for colorectal cancer patients and exploration of the biological functions of NOS2 in vivo and in vitro","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0387","article-title":"Infiltration of tumors is regulated by T cell\u2013intrinsic nitric oxide synthesis","volume":"11","author":"Cunha","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216931","article-title":"Unveiling the significance of inducible nitric oxide synthase: Its impact on cancer progression and clinical implications","volume":"592","author":"Chen","year":"2024","journal-title":"Cancer Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.53","article-title":"The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis","volume":"10","author":"Thiele Orberg","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s10020-025-01099-4","article-title":"Harnessing amino acid pathways to influence myeloid cell function in tumor immunity","volume":"31","author":"Pan","year":"2025","journal-title":"Mol Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0492-9","article-title":"Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis","volume":"38","author":"Coburn","year":"2019","journal-title":"Oncogene"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126923","article-title":"Arginase impedes the resolution of colitis by altering the microbiome and metabolome","volume":"130","author":"Baier","year":"2020","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00303.2021","article-title":"Emodin reduces tumor burden by diminishing M2-like macrophages in colorectal cancer","volume":"322","author":"Sougiannis","year":"2022","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2024.25.4.1357","article-title":"M2 macrophage prominently distributed in the rat\u2019s colon of DMH-induced inflammation associated colorectal cancer","volume":"25","author":"Omadhika","year":"2024","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123805","article-title":"Regulation of iNOS on immune cells and its role in diseases","volume":"19","author":"Xue","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.06.011","article-title":"Tumor cells modulate macrophage phenotype in a novel in vitro co-culture model of the NSCLC tumor microenvironment","volume":"17","author":"Park","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived Arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s246714","article-title":"Cancer-derived transforming growth factor-\u03b2 Modulates tumor-associated macrophages in ampullary cancer","volume":"13","author":"Cheng","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"24669","DOI":"10.1038\/s41598-024-75882-4","article-title":"The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1373820","article-title":"Correlation between Tregs and ICOS-induced M2 macrophages polarization in colorectal cancer progression","volume":"14","author":"Xu","year":"2024","journal-title":"Front Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1084636","article-title":"The markers to delineate different phenotypes of macrophages related to metabolic disorders","volume":"14","author":"Wei","year":"2023","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01875","article-title":"The two faces of tumor-associated macrophages and their clinical significance in colorectal cancer","volume":"10","author":"Pinto","year":"2019","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/tub-211571","article-title":"Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable","volume":"44","author":"Kasurinen","year":"2022","journal-title":"Tumor Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41698-024-00660-4","article-title":"Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census","volume":"8","author":"Wei","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14103","article-title":"Elevations of monocyte and neutrophils, and higher levels of granulocyte colony-stimulating factor in peripheral blood in lung cancer patients","volume":"12","author":"Yin","year":"2021","journal-title":"Thorac Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.62347\/IPTW9741","article-title":"Characterization of blood inflammatory markers in patients with non-small cell lung cancer","volume":"17","author":"Zhai","year":"2024","journal-title":"Int J Clin Exp Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1543055","article-title":"Combined CA125, NSE, and multiple inflammatory indices for diagnosis of oral squamous cell carcinoma","volume":"15","author":"Abudukelimu","year":"2025","journal-title":"Front Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1415804","article-title":"Increased neutrophil counts are associated with poor overall survival in patients with colorectal cancer: a five-year retrospective analysis","volume":"15","author":"Garcia-Flores","year":"2024","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41598-023-50378-9","article-title":"Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer","volume":"14","author":"Ohashi","year":"2024","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568825","article-title":"Neutrophil-to-lymphocyte ratio predicts a poor prognosis for penile cancer with an immunosuppressive tumor microenvironment","volume":"16","author":"Tan","year":"2025","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S211089","article-title":"Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy","volume":"11","author":"Jiang","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231212184","article-title":"Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab","volume":"15","author":"Passardi","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10275","article-title":"Pretreatment PLR is preferable to NLR and LMR as a predictor in locally advanced and metastatic bladder cancer","volume":"3","author":"Karan","year":"2023","journal-title":"Cancer Diagnosis Prognosis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.908907","article-title":"Prognostic significance of NLR, PLR, LMR and tumor infiltrating T lymphocytes in patients undergoing surgical resection for Hilar cholangiocarcinoma","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2478\/fco-2023-0021","article-title":"Prognostic value of pro-inflammatory markers at the preoperative stage in Algerian women with breast cancer","volume":"14","author":"Zergoun","year":"2023","journal-title":"Forum Clin Oncol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12957-021-02426-9","article-title":"The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection","volume":"19","author":"Qiang","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-024-01493-z","article-title":"ARG1 is a potential prognostic marker in metastatic endometrial cancer","volume":"31","author":"Tran","year":"2024","journal-title":"Reprod Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202502402","article-title":"Abnormal \u03b2-hydroxybutyrylation modification of ARG1 drives reprogramming of arginine metabolism to promote the progression of colorectal cancer","volume":"12","author":"Lin","year":"2025","journal-title":"Advanced Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1038\/s41598-025-88966-6","article-title":"NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis","volume":"15","author":"Xing","year":"2025","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/s12951-024-02929-z","article-title":"Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer","volume":"22","author":"Tang","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1186\/s12967-024-05652-3","article-title":"Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment","volume":"22","author":"Wang","year":"2024","journal-title":"J Trans Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S450585","article-title":"Correlation between NLR combined with PLR score and prognosis of hepatocellular carcinoma after liver transplantation","volume":"17","author":"Niu","year":"2024","journal-title":"Int J Gen Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"9898","DOI":"10.1038\/s41598-024-59131-2","article-title":"Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1700487\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:35:56Z","timestamp":1767771356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1700487\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2025.1700487"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1700487","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1700487"}}